Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Macrogenics (MGNX) Other Accumulated Expenses (2017 - 2019)

Macrogenics (MGNX) has disclosed Other Accumulated Expenses for 6 consecutive years, with $175000.0 as the latest value for Q3 2019.

  • Quarterly Other Accumulated Expenses changed 0.0% to $175000.0 in Q3 2019 from the year-ago period, while the trailing twelve-month figure was $175000.0 through Sep 2019, changed 0.0% year-over-year, with the annual reading at $175000.0 for FY2018, 63.0% down from the prior year.
  • Other Accumulated Expenses for Q3 2019 was $175000.0 at Macrogenics, roughly flat from $175000.0 in the prior quarter.
  • The five-year high for Other Accumulated Expenses was $1.6 million in Q1 2015, with the low at $175000.0 in Q3 2017.
  • Average Other Accumulated Expenses over 4 years is $570384.6, with a median of $175000.0 recorded in 2017.
  • The sharpest move saw Other Accumulated Expenses soared 342.25% in 2015, then plummeted 63.0% in 2018.
  • Over 4 years, Other Accumulated Expenses stood at $727000.0 in 2015, then tumbled by 34.94% to $473000.0 in 2017, then tumbled by 63.0% to $175000.0 in 2018, then changed by 0.0% to $175000.0 in 2019.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods came in at $175000.0, $175000.0, and $175000.0 for Q3 2019, Q2 2019, and Q1 2019 respectively.